KEGG   PATHWAY: hgl04931
Entry
hgl04931                    Pathway                                
Name
Insulin resistance - Heterocephalus glaber (naked mole-rat)
Description
Insulin resistance is a condition where cells become resistant to the effects of insulin. It is often found in people with health disorders, including obesity, type 2 diabetes mellitus, non-alcoholic fatty liver disease, and cardiovascular diseases. In this diagram multiple mechanisms underlying insulin resistance are shown: (a) increased phosphorylation of IRS (insulin receptor substrate) protein through serine/threonine kinases, such as JNK1 and IKKB, and protein kinase C, (b) increased IRS-1 proteasome degradation via mTOR signaling pathway, (c) decreased activation of signaling molecules including PI3K and AKT, (d) increase in activity of phosphatases including PTPs, PTEN, and PP2A. Regulatory actions such as oxidative stress, mitochondrial dysfunction, accumulation of intracellular lipid derivatives (diacylglycrol and ceramides), and inflammation (via IL-6 and TNFA) contribute to these mechanisms. Consequently, insulin resistance causes reduced GLUT4 translocation, resulting in glucose takeup and glycogen synthesis in skeletal muscle as well as increased hepatic gluconeogenesis and decreased glycogen synthesis in liver. At the bottom of the diagram, interplay between O-GlcNAcylation and serine/threonine phosphorylation is shown. Studies suggested that elevated O-GlcNAc level was correlated to high glucose-induced insulin resistance. Donor UDP-GlcNAc is induced through hexosamine biosynthesis pathway and added to proteins by O-GlcNAc transferase. Elevation of O-GlcNAc modification alters phosphorylation and function of key insulin signaling proteins including IRS-1, PI3K, PDK1, Akt and other transcription factor and cofactors, resulting in the attenuation of insulin signaling cascade.
Class
Human Diseases; Endocrine and metabolic disease
Pathway map
hgl04931  Insulin resistance
hgl04931

Organism
Heterocephalus glaber (naked mole-rat) [GN:hgl]
Gene
101719971  Ins; insulin [KO:K04526]
101712979  Rps6ka1; ribosomal protein S6 kinase A1 [KO:K04373] [EC:2.7.11.1]
101708473  Rps6ka2; ribosomal protein S6 kinase A2 [KO:K04373] [EC:2.7.11.1]
101722051  Rps6ka3; ribosomal protein S6 kinase A3 [KO:K04373] [EC:2.7.11.1]
101703020  Rps6ka6; ribosomal protein S6 kinase A6 [KO:K04373] [EC:2.7.11.1]
101714468  Ppp1cc; protein phosphatase 1 catalytic subunit gamma [KO:K06269] [EC:3.1.3.16]
101698044  Ppp1cb; protein phosphatase 1 catalytic subunit beta [KO:K06269] [EC:3.1.3.16]
101705408  Ppp1ca; protein phosphatase 1 catalytic subunit alpha [KO:K06269] [EC:3.1.3.16]
101722711  Ppp1r3c; protein phosphatase 1 regulatory subunit 3C [KO:K07189]
101716224  Ppp1r3e; protein phosphatase 1 regulatory subunit 3E [KO:K07189]
101699914  Ppp1r3a; protein phosphatase 1 regulatory subunit 3A [KO:K07189]
101718103  Ppp1r3b; protein phosphatase 1 regulatory subunit 3B [KO:K07189]
101722168  Insr; insulin receptor [KO:K04527] [EC:2.7.10.1]
101708189  Irs1; insulin receptor substrate 1 [KO:K16172]
101696680  Ptpn1; protein tyrosine phosphatase, non-receptor type 1 [KO:K05696] [EC:3.1.3.48]
101701336  Ptpn11; protein tyrosine phosphatase, non-receptor type 11 [KO:K07293] [EC:3.1.3.48]
101711685  Ptprf; protein tyrosine phosphatase, receptor type F [KO:K05695] [EC:3.1.3.48]
101717371  receptor-type tyrosine-protein phosphatase F-like [KO:K05695] [EC:3.1.3.48]
101711934  Pik3ca; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [KO:K00922] [EC:2.7.1.153]
101715249  Pik3cb; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [KO:K00922] [EC:2.7.1.153]
101712941  Pik3cd; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [KO:K00922] [EC:2.7.1.153]
101718815  Pik3r2; phosphoinositide-3-kinase regulatory subunit 2 [KO:K02649]
101717096  Pik3r3; phosphatidylinositol 3-kinase regulatory subunit gamma [KO:K02649]
101703691  Pik3r1; phosphoinositide-3-kinase regulatory subunit 1 [KO:K02649]
101700695  Akt1; AKT serine/threonine kinase 1 [KO:K04456] [EC:2.7.11.1]
101719164  Akt2; AKT serine/threonine kinase 2 [KO:K04456] [EC:2.7.11.1]
101701289  Akt3; AKT serine/threonine kinase 3 [KO:K04456] [EC:2.7.11.1]
101725626  Mtor; mechanistic target of rapamycin [KO:K07203] [EC:2.7.11.1]
101702911  Rps6kb2; ribosomal protein S6 kinase B2 [KO:K04688] [EC:2.7.11.1]
101724077  Rps6kb1; ribosomal protein S6 kinase B1 [KO:K04688] [EC:2.7.11.1]
101722702  Prkcb; protein kinase C beta [KO:K19662] [EC:2.7.11.13]
101702602  Il6; interleukin 6 [KO:K05405]
101721899  Stat3; signal transducer and activator of transcription 3 [KO:K04692]
101704157  Socs3; suppressor of cytokine signaling 3 [KO:K04696]
101701301  Gsk3b; glycogen synthase kinase 3 beta [KO:K03083] [EC:2.7.11.26]
101699800  Gys2; glycogen synthase 2 [KO:K00693] [EC:2.4.1.11]
101712358  Gys1; glycogen synthase 1 [KO:K00693] [EC:2.4.1.11]
101718432  Tnf; tumor necrosis factor [KO:K03156]
101698980  Tnfrsf1a; TNF receptor superfamily member 1A [KO:K03158]
101698286  Mapk9; mitogen-activated protein kinase 9 [KO:K04440] [EC:2.7.11.24]
101715259  Mapk8; mitogen-activated protein kinase 8 [KO:K04440] [EC:2.7.11.24]
101712980  Mapk10; mitogen-activated protein kinase 10 [KO:K04440] [EC:2.7.11.24]
101711077  Ikbkb; inhibitor of nuclear factor kappa B kinase subunit beta [KO:K07209] [EC:2.7.11.10]
101709256  Nfkbia; NFKB inhibitor alpha [KO:K04734]
101696485  Nfkb1; nuclear factor kappa B subunit 1 [KO:K02580]
101716738  Rela; RELA proto-oncogene, NF-kB subunit [KO:K04735]
101711110  Nos3; nitric oxide synthase 3 [KO:K13242] [EC:1.14.13.39]
101699303  Prkcz; protein kinase C zeta [KO:K18952] [EC:2.7.11.13]
101719700  Tbc1d4; TBC1 domain family member 4 [KO:K17902]
101714675  Slc2a4; solute carrier family 2 member 4 [KO:K07191]
101698482  Prkaa2; protein kinase AMP-activated catalytic subunit alpha 2 [KO:K07198] [EC:2.7.11.31]
101722998  Prkaa1; protein kinase AMP-activated catalytic subunit alpha 1 [KO:K07198] [EC:2.7.11.31]
101705863  Prkab1; protein kinase AMP-activated non-catalytic subunit beta 1 [KO:K07199]
101720100  Prkab2; protein kinase AMP-activated non-catalytic subunit beta 2 [KO:K07199]
101699641  Prkag2; protein kinase AMP-activated non-catalytic subunit gamma 2 [KO:K07200]
101699667  Prkag3; protein kinase AMP-activated non-catalytic subunit gamma 3 [KO:K07200]
101721085  Prkag1; protein kinase AMP-activated non-catalytic subunit gamma 1 [KO:K07200]
101717399  Acacb; acetyl-CoA carboxylase beta [KO:K01946] [EC:6.4.1.2 6.3.4.14 2.1.3.15]
101724285  Cpt1b; carnitine palmitoyltransferase 1B [KO:K19523] [EC:2.3.1.21]
101717217  Agt; angiotensinogen [KO:K09821]
101712627  Slc27a1; solute carrier family 27 member 1 [KO:K08745] [EC:6.2.1.-]
101696617  Slc27a4; solute carrier family 27 member 4 [KO:K08745] [EC:6.2.1.-]
101712294  Slc27a2; solute carrier family 27 member 2 [KO:K08746] [EC:6.2.1.- 6.2.1.3]
101711552  Slc27a3; solute carrier family 27 member 3 [KO:K08772] [EC:6.2.1.-]
101724180  Slc27a5; solute carrier family 27 member 5 [KO:K08748] [EC:6.2.1.7]
101702783  Slc27a6; solute carrier family 27 member 6 [KO:K08749]
101703900  Cd36; CD36 molecule [KO:K06259]
101724103  Prkcq; protein kinase C theta [KO:K18052] [EC:2.7.11.13]
101718422  Prkcd; protein kinase C delta [KO:K06068] [EC:2.7.11.13]
101705651  Ptpa; protein phosphatase 2 phosphatase activator [KO:K17605]
101705277  Srebf1; sterol regulatory element binding transcription factor 1 [KO:K07197]
101719081  Irs2; insulin receptor substrate 2 [KO:K07187]
101716331  Trib3; tribbles pseudokinase 3 [KO:K19518]
101723998  Pygl; glycogen phosphorylase L [KO:K00688] [EC:2.4.1.1]
101717341  Pygb; glycogen phosphorylase B [KO:K00688] [EC:2.4.1.1]
101713354  Pygm; glycogen phosphorylase, muscle associated [KO:K00688] [EC:2.4.1.1]
101707441  Foxo1; forkhead box O1 [KO:K07201]
101708730  Pck1; phosphoenolpyruvate carboxykinase 1 [KO:K01596] [EC:4.1.1.32]
101706336  Pck2; phosphoenolpyruvate carboxykinase 2, mitochondrial [KO:K01596] [EC:4.1.1.32]
101715644  G6pc2; glucose-6-phosphatase catalytic subunit 2 [KO:K01084] [EC:3.1.3.9]
101708598  G6pc; glucose-6-phosphatase catalytic subunit [KO:K01084] [EC:3.1.3.9]
101723886  G6pc3; glucose-6-phosphatase catalytic subunit 3 [KO:K01084] [EC:3.1.3.9]
101699012  Slc2a2; solute carrier family 2 member 2 [KO:K07593]
101709627  Nr1h3; nuclear receptor subfamily 1 group H member 3 [KO:K08536]
101700273  Nr1h2; nuclear receptor subfamily 1 group H member 2 [KO:K08535]
101717446  Ppargc1b; PPARG coactivator 1 beta [KO:K17962]
101703432  Mlxipl; MLX interacting protein like [KO:K09113]
101706955  Mlxip; MLX interacting protein [KO:K09113]
101716781  Mlx; MLX, MAX dimerization protein [KO:K09113]
101716055  Cpt1a; carnitine palmitoyltransferase 1A [KO:K08765] [EC:2.3.1.21]
101700837  Prkce; protein kinase C epsilon [KO:K18050] [EC:2.7.11.13]
101703716  Ppargc1a; PPARG coactivator 1 alpha [KO:K07202]
101725514  Ppara; peroxisome proliferator activated receptor alpha [KO:K07294]
101709940  Pdpk1; 3-phosphoinositide dependent protein kinase 1 [KO:K06276] [EC:2.7.11.1]
101714930  Pten; phosphatase and tensin homolog [KO:K01110] [EC:3.1.3.16 3.1.3.48 3.1.3.67]
101702515  Mgea5; meningioma expressed antigen 5 (hyaluronidase) [KO:K15719] [EC:3.2.1.169 2.3.1.48]
101710902  UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit [KO:K09667] [EC:2.4.1.255]
101721730  Ogt; O-linked N-acetylglucosamine (GlcNAc) transferase [KO:K09667] [EC:2.4.1.255]
101697875  Slc2a1; solute carrier family 2 member 1 [KO:K07299]
101710677  Gfpt2; glutamine-fructose-6-phosphate transaminase 2 [KO:K00820] [EC:2.6.1.16]
101700913  Gfpt1; glutamine--fructose-6-phosphate transaminase 1 [KO:K00820] [EC:2.6.1.16]
101709168  Crtc2; CREB regulated transcription coactivator 2 [KO:K16333]
101712503  Creb1; cAMP responsive element binding protein 1 [KO:K05870]
101715715  Creb3l2; cAMP responsive element binding protein 3 like 2 [KO:K09048]
101698748  Creb3l1; cAMP responsive element binding protein 3 like 1 [KO:K09048]
101716023  Creb3l3; cAMP responsive element binding protein 3 like 3 [KO:K09048]
101706643  Creb3l4; cAMP responsive element binding protein 3 like 4 [KO:K09048]
101718447  Creb3; cAMP responsive element binding protein 3 [KO:K09048]
101703315  Creb5; cAMP responsive element binding protein 5 [KO:K09047]
Compound
C00022  Pyruvate
C00024  Acetyl-CoA
C00031  D-Glucose
C00043  UDP-N-acetyl-alpha-D-glucosamine
C00083  Malonyl-CoA
C00085  D-Fructose 6-phosphate
C00092  D-Glucose 6-phosphate
C00095  D-Fructose
C00162  Fatty acid
C00165  Diacylglycerol
C00195  N-Acylsphingosine
C00352  D-Glucosamine 6-phosphate
C00369  Starch
C00422  Triacylglycerol
C00533  Nitric oxide
C02571  O-Acetylcarnitine
C02843  Long-chain acyl-CoA
C05981  Phosphatidylinositol-3,4,5-trisphosphate
C06156  alpha-D-Glucosamine 1-phosphate
G00369   
Reference
  Authors
Martins AR, Nachbar RT, Gorjao R, Vinolo MA, Festuccia WT, Lambertucci RH, Cury-Boaventura MF, Silveira LR, Curi R, Hirabara SM
  Title
Mechanisms underlying skeletal muscle insulin resistance induced by fatty acids: importance of the mitochondrial function.
  Journal
Lipids Health Dis 11:30 (2012)
DOI:10.1186/1476-511X-11-30
Reference
  Authors
Bouzakri K, Roques M, Gual P, Espinosa S, Guebre-Egziabher F, Riou JP, Laville M, Le Marchand-Brustel Y, Tanti JF, Vidal H
  Title
Reduced activation of phosphatidylinositol-3 kinase and increased serine 636 phosphorylation of insulin receptor substrate-1 in primary culture of skeletal muscle cells from patients with type 2 diabetes.
  Journal
Diabetes 52:1319-25 (2003)
DOI:10.2337/diabetes.52.6.1319
Reference
  Authors
Choi K, Kim YB
  Title
Molecular mechanism of insulin resistance in obesity and type 2 diabetes.
  Journal
Korean J Intern Med 25:119-29 (2010)
DOI:10.3904/kjim.2010.25.2.119
Reference
PMID:7666792
  Authors
Ahmad F, Goldstein BJ
  Title
Increased abundance of specific skeletal muscle protein-tyrosine phosphatases in a genetic model of insulin-resistant obesity and diabetes mellitus.
  Journal
Metabolism 44:1175-84 (1995)
DOI:10.1016/0026-0495(95)90012-8
Reference
  Authors
George S, Rochford JJ, Wolfrum C, Gray SL, Schinner S, Wilson JC, Soos MA, Murgatroyd PR, Williams RM, Acerini CL, Dunger DB, Barford D, Umpleby AM, Wareham NJ, Davies HA, Schafer AJ, Stoffel M, O'Rahilly S, Barroso I
  Title
A family with severe insulin resistance and diabetes due to a mutation in AKT2.
  Journal
Science 304:1325-8 (2004)
DOI:10.1126/science.1096706
Reference
  Authors
Snel M, Jonker JT, Schoones J, Lamb H, de Roos A, Pijl H, Smit JW, Meinders AE, Jazet IM
  Title
Ectopic fat and insulin resistance: pathophysiology and effect of diet and lifestyle interventions.
  Journal
Int J Endocrinol 2012:983814 (2012)
DOI:10.1155/2012/983814
Reference
  Authors
Morino K, Petersen KF, Shulman GI
  Title
Molecular mechanisms of insulin resistance in humans and their potential links with mitochondrial dysfunction.
  Journal
Diabetes 55 Suppl 2:S9-S15 (2006)
DOI:10.2337/db06-S002
Reference
  Authors
Plomgaard P, Bouzakri K, Krogh-Madsen R, Mittendorfer B, Zierath JR, Pedersen BK
  Title
Tumor necrosis factor-alpha induces skeletal muscle insulin resistance in healthy human subjects via inhibition of Akt substrate 160 phosphorylation.
  Journal
Diabetes 54:2939-45 (2005)
DOI:10.2337/diabetes.54.10.2939
Reference
  Authors
Kim JA, Wei Y, Sowers JR
  Title
Role of mitochondrial dysfunction in insulin resistance.
  Journal
Circ Res 102:401-14 (2008)
DOI:10.1161/CIRCRESAHA.107.165472
Reference
  Authors
Steinberg GR, Michell BJ, van Denderen BJ, Watt MJ, Carey AL, Fam BC, Andrikopoulos S, Proietto J, Gorgun CZ, Carling D, Hotamisligil GS, Febbraio MA, Kay TW, Kemp BE
  Title
Tumor necrosis factor alpha-induced skeletal muscle insulin resistance involves suppression of AMP-kinase signaling.
  Journal
Cell Metab 4:465-74 (2006)
DOI:10.1016/j.cmet.2006.11.005
Reference
PMID:9886945
  Authors
Ruderman NB, Saha AK, Vavvas D, Witters LA
  Title
Malonyl-CoA, fuel sensing, and insulin resistance.
  Journal
Am J Physiol 276:E1-E18 (1999)
DOI:10.1152/ajpendo.1999.276.1.E1
Reference
PMID:8048519
  Authors
Saha AK, Kurowski TG, Colca JR, Ruderman NB
  Title
Lipid abnormalities in tissues of the KKAy mouse: effects of pioglitazone on malonyl-CoA and diacylglycerol.
  Journal
Am J Physiol 267:E95-101 (1994)
DOI:10.1152/ajpendo.1994.267.1.E95
Reference
  Authors
Blachnio-Zabielska AU, Koutsari C, Tchkonia T, Jensen MD
  Title
Sphingolipid content of human adipose tissue: relationship to adiponectin and insulin resistance.
  Journal
Obesity (Silver Spring) 20:2341-7 (2012)
DOI:10.1038/oby.2012.126
Reference
  Authors
Larter CZ, Farrell GC
  Title
Insulin resistance, adiponectin, cytokines in NASH: Which is the best target to treat?
  Journal
J Hepatol 44:253-61 (2006)
DOI:10.1016/j.jhep.2005.11.030
Reference
  Authors
Koo SH, Satoh H, Herzig S, Lee CH, Hedrick S, Kulkarni R, Evans RM, Olefsky J, Montminy M
  Title
PGC-1 promotes insulin resistance in liver through PPAR-alpha-dependent induction of TRB-3.
  Journal
Nat Med 10:530-4 (2004)
DOI:10.1038/nm1044
Reference
  Authors
Slawson C, Copeland RJ, Hart GW
  Title
O-GlcNAc signaling: a metabolic link between diabetes and cancer?
  Journal
Trends Biochem Sci 35:547-55 (2010)
DOI:10.1016/j.tibs.2010.04.005
Reference
  Authors
Ruan HB, Singh JP, Li MD, Wu J, Yang X
  Title
Cracking the O-GlcNAc code in metabolism.
  Journal
Trends Endocrinol Metab 24:301-9 (2013)
DOI:10.1016/j.tem.2013.02.002
Reference
  Authors
Muoio DM, Newgard CB
  Title
Obesity-related derangements in metabolic regulation.
  Journal
Annu Rev Biochem 75:367-401 (2006)
DOI:10.1146/annurev.biochem.75.103004.142512
Reference
  Authors
Itani SI, Zhou Q, Pories WJ, MacDonald KG, Dohm GL
  Title
Involvement of protein kinase C in human skeletal muscle insulin resistance and obesity.
  Journal
Diabetes 49:1353-8 (2000)
DOI:10.2337/diabetes.49.8.1353
Related
pathway
hgl00010  Glycolysis / Gluconeogenesis
hgl00061  Fatty acid biosynthesis
hgl00514  Other types of O-glycan biosynthesis
hgl00520  Amino sugar and nucleotide sugar metabolism
hgl04150  mTOR signaling pathway
hgl04151  PI3K-Akt signaling pathway
hgl04668  TNF signaling pathway
hgl04910  Insulin signaling pathway
KO pathway
ko04931   
LinkDB

DBGET integrated database retrieval system